259 related articles for article (PubMed ID: 16835711)
21. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
Tang BD; Zeng ZR; Hu PJ
Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
[TBL] [Abstract][Full Text] [Related]
22. Allopurinol prevents early alcohol-induced liver injury in rats.
Kono H; Rusyn I; Bradford BU; Connor HD; Mason RP; Thurman RG
J Pharmacol Exp Ther; 2000 Apr; 293(1):296-303. PubMed ID: 10734182
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous and intra-abdominal abscess formation in rats following radio frequency [corrected] ablation of liver tumors in combination with celecoxib treatment.
De Heer P; Sandel MH; Speetjens FM; Koudijs MM; Putter H; Ensink GN; Van de Velde CJ; Kuppen PJ
In Vivo; 2006; 20(3):373-5. PubMed ID: 16724673
[TBL] [Abstract][Full Text] [Related]
24. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.
Paik YH; Kim JK; Lee JI; Kang SH; Kim DY; An SH; Lee SJ; Lee DK; Han KH; Chon CY; Lee SI; Lee KS; Brenner DA
Gut; 2009 Nov; 58(11):1517-27. PubMed ID: 19201774
[TBL] [Abstract][Full Text] [Related]
25. Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.
Narayanan BA; Reddy BS; Bosland MC; Nargi D; Horton L; Randolph C; Narayanan NK
Clin Cancer Res; 2007 Oct; 13(19):5965-73. PubMed ID: 17908994
[TBL] [Abstract][Full Text] [Related]
26. Ethanol modulates gut ischemia/reperfusion-induced liver injury in rats.
Yamagishi Y; Horie Y; Kato S; Kajihara M; Tamai H; Granger DN; Ishii H
Am J Physiol Gastrointest Liver Physiol; 2002 Apr; 282(4):G640-6. PubMed ID: 11897623
[TBL] [Abstract][Full Text] [Related]
27. Involvement of Toll-like receptor 4 in acetaminophen hepatotoxicity.
Yohe HC; O'Hara KA; Hunt JA; Kitzmiller TJ; Wood SG; Bement JL; Bement WJ; Szakacs JG; Wrighton SA; Jacobs JM; Kostrubsky V; Sinclair PR; Sinclair JF
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1269-79. PubMed ID: 16439473
[TBL] [Abstract][Full Text] [Related]
28. The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials.
Soni P; Shell B; Cawkwell G; Li C; Ma H
Curr Med Res Opin; 2009 Aug; 25(8):1841-51. PubMed ID: 19530981
[TBL] [Abstract][Full Text] [Related]
29. Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain.
Guo JY; Li CY; Ruan YP; Sun M; Qi XL; Zhao BS; Luo F
Eur J Pharmacol; 2009 Jun; 612(1-3):54-60. PubMed ID: 19356723
[TBL] [Abstract][Full Text] [Related]
30. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
Hong XZ; Li LD; Wu LM
Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
[TBL] [Abstract][Full Text] [Related]
31. Lack of sexual dimorphism in alcohol-induced liver damage (ALD) in rats treated chronically with ethanol-containing low carbohydrate diets: The role of ethanol metabolism and endotoxin.
Ronis MJ; Korourian S; Yoon S; Ingelman-Sundberg M; Albano E; Lindros KO; Badger TM
Life Sci; 2004 Jun; 75(4):469-83. PubMed ID: 15147833
[TBL] [Abstract][Full Text] [Related]
32. Effect of celecoxib, a cyclooxygenase-2 inhibitor, on the pathophysiology of adjuvant arthritis in rat.
Noguchi M; Kimoto A; Kobayashi S; Yoshino T; Miyata K; Sasamata M
Eur J Pharmacol; 2005 Apr; 513(3):229-35. PubMed ID: 15862805
[TBL] [Abstract][Full Text] [Related]
33. Effects of glutamine administration on inflammatory responses in chronic ethanol-fed rats.
Peng HC; Chen YL; Chen JR; Yang SS; Huang KH; Wu YC; Lin YH; Yang SC
J Nutr Biochem; 2011 Mar; 22(3):282-8. PubMed ID: 20573494
[TBL] [Abstract][Full Text] [Related]
34. Complement C3 contributes to ethanol-induced liver steatosis in mice.
Bykov I; Junnikkala S; Pekna M; Lindros KO; Meri S
Ann Med; 2006; 38(4):280-6. PubMed ID: 16754259
[TBL] [Abstract][Full Text] [Related]
35. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
[TBL] [Abstract][Full Text] [Related]
36. Fat diet and alcohol-induced steatohepatitis after LPS challenge in mice: role of bioactive TNF and Th1 type cytokines.
Olleros ML; Martin ML; Vesin D; Fotio AL; Santiago-Raber ML; Rubbia-Brandt L; Spahr L; Hadengue A; Garcia I
Cytokine; 2008 Oct; 44(1):118-25. PubMed ID: 18722787
[TBL] [Abstract][Full Text] [Related]
37. Effect of a herbal medicine on fatty liver in rats fed ethanol chronically.
Horie Y; Kikuchi M; Yamagishi Y; Umeda R; Ebinuma H; Saito H; Kato S; Ishii H; Hibi T; Han JY
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2009 Dec; 44(6):636-48. PubMed ID: 20077758
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
[TBL] [Abstract][Full Text] [Related]
39. Lysosomal leakage and lack of adaptation of hepatoprotective enzyme contribute to enhanced susceptibility to ethanol-induced liver injury in female rats.
Donohue TM; Curry-McCoy TV; Nanji AA; Kharbanda KK; Osna NA; Radio SJ; Todero SL; White RL; Casey CA
Alcohol Clin Exp Res; 2007 Nov; 31(11):1944-52. PubMed ID: 17850215
[TBL] [Abstract][Full Text] [Related]
40. Action of celecoxib on hepatic metabolic changes induced by the Walker-256 tumour in rats.
Acco A; Alves da Silva MH; Batista MR; Yamamoto NS; Bracht A
Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):294-300. PubMed ID: 17910611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
